These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 13748260)

  • 1. [Simian viruses as a factor of uncertainty in evaluation of innocuousness of poliomyelitis vaccines in tissue cultures].
    SCHNEIDER W; FINGER H
    Arch Gesamte Virusforsch; 1961; 11():197-208. PubMed ID: 13748260
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunogenicity studies in human subjects of trivalent tissue culture poliomyelitis vaccine inactivated by ultraviolet irradiation.
    MILZER A; LEVINSON SO; SHAUGHNESSY HJ; JANOTA M; VANDERBOOM K; OPPENHEIMER F
    Am J Public Health Nations Health; 1954 Jan; 44(1):26-33. PubMed ID: 13114481
    [No Abstract]   [Full Text] [Related]  

  • 3. ["Poliomyelitis in Indonesia". Orientations in serological and epidemiological research based on tissue culture].
    LIE KT
    Madjalah Kedokt Indones; 1959 Nov; 9():465-74. PubMed ID: 13853674
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antibody titers in man after inoculation with charge 7, Behringwerke poliomyelitis vaccine].
    KELLER W; SAUTHOFF R
    Klin Wochenschr; 1955 Aug; 33(29-30):732. PubMed ID: 13264518
    [No Abstract]   [Full Text] [Related]  

  • 5. Cultivation of the Lansing Strain of Poliomyelitis Virus in Cultures of Various Human Embryonic Tissues.
    Enders JF; Weller TH; Robbins FC
    Science; 1949 Jan; 109(2822):85-7. PubMed ID: 17794160
    [No Abstract]   [Full Text] [Related]  

  • 6. Factors influencing the potency of poliomyelitis complement-fixing antigens produced in tissue-culture systems.
    SCHMIDT NJ; LENNETTE EH; DOLEMAN JH; HAGENS SJ
    Am J Hyg; 1957 Jul; 66(1):1-19. PubMed ID: 13444252
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the absence in French vaccine of the vacuolating agent (SV40 virus)].
    LEPINE P; SAUTTER V
    Bull Acad Natl Med; 1962 Feb 6-13; 146():112-5. PubMed ID: 14464170
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the antigenicity of vaccines against poliomyelitis. Inactivated vaccines and vaccinations by attenuated living viruses].
    LEPINE P
    Bull Acad Natl Med; 1960 Jun 5-Jul 28; 144():480-98. PubMed ID: 14415887
    [No Abstract]   [Full Text] [Related]  

  • 9. [Neutralization test with Lansing poliomyelitis virus in mice and tissue cultures].
    EGGERS HJ
    Arch Gesamte Virusforsch; 1957; 7(2):136-42. PubMed ID: 13395383
    [No Abstract]   [Full Text] [Related]  

  • 10. [The significance of the results of metabolism determinations and transplantation experiments for the usefulness of certain tissue culture systems in the production of Salk vaccine].
    SAUTHOFF R; LUTHARDT T; MITTELSTRASS HK
    Klin Wochenschr; 1960 Sep; 38():893-9. PubMed ID: 13746837
    [No Abstract]   [Full Text] [Related]  

  • 11. [The kinetic reaction of serological neutralization of poliomyelitis viruses in cell cultures. II. Application to the study of the antigenicity of antipoliomyelitic vaccines on chicks. (Method of the Pasteur Institute)].
    LEPINE P; ROGER F; SAUTTER V; ROGER A
    Bull World Health Organ; 1960; 22(3-4):273-89. PubMed ID: 14415883
    [No Abstract]   [Full Text] [Related]  

  • 12. Poliomyelitis Viruses in Tissue Culture.
    Melnick JL
    Science; 1952 Jun; 115(2998):3. PubMed ID: 17844306
    [No Abstract]   [Full Text] [Related]  

  • 13. Tissue cultures of KB epithelial cells for poliomyelitis virus tests.
    LUOTO L; PICKENS EG
    Public Health Rep (1896); 1958 Jun; 73(6):541-4. PubMed ID: 13568000
    [No Abstract]   [Full Text] [Related]  

  • 14. Noncytopathogenic variants of poliomyelitis viruses and resistance to superinfection in tissue culture.
    SABIN AB
    Science; 1954 Aug; 120(3113):357. PubMed ID: 13186860
    [No Abstract]   [Full Text] [Related]  

  • 15. [Frequency and antibody titers of three types of poliomyelitis in the population of Naples].
    BRANCATO P; PICCIOTTO L; POSTERARO G
    Riv Ist Sieroter Ital; 1956; 31(3):236-40. PubMed ID: 13380272
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of poliomyelitis virus upon cells in tissue cultures.
    ROBBINS FC; ENDERS JF; WELLER TH
    J Clin Invest; 1950 Jun; 29(6):841. PubMed ID: 15436812
    [No Abstract]   [Full Text] [Related]  

  • 17. Differences in cellular pathogenicity of two immunologically related poliomyelitis viruses as revealed in tissue culture.
    LEDINKO N; RIORDAN JT; MELNICK JL
    Proc Soc Exp Biol Med; 1951 Oct; 78(1):83-8. PubMed ID: 14891928
    [No Abstract]   [Full Text] [Related]  

  • 18. A study of the poliomyelitis antibody titre in donor sera and in human gamma-globulin.
    GENDON IuZ; KHEIT SL
    J Hyg Epidemiol Microbiol Immunol; 1960; 4():103-7. PubMed ID: 13827270
    [No Abstract]   [Full Text] [Related]  

  • 19. Laboratory studies in connection with the evaluation of poliomyelitis vaccine, Toronto, 1955.
    BEALE AJ; BALASUBRAMANIAN A; MCLEOD DL; DAVIS N; STACKIW W; MCNAUGHTON GA; RHODES AJ
    Can J Public Health; 1957 Jun; 48(6):223-8. PubMed ID: 13437236
    [No Abstract]   [Full Text] [Related]  

  • 20. [Principles of government tests of live poliomyelitis vaccines].
    BONIN O
    Dtsch Med Wochenschr; 1961 Dec; 86():2316-22. PubMed ID: 13871013
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.